Stoppe, Christian
Patel, Jayshil J.
Zarbock, Alex
Lee, Zheng-Yii
Rice, Todd W.
Mafrici, Bruno
Wehner, Rebecca
Chan, Man Hung Manuel
Lai, Peter Chi Keung
MacEachern, Kristen
Myrianthefs, Pavlos
Tsigou, Evdoxia
Ortiz-Reyes, Luis
Jiang, Xuran
Day, Andrew G.
Hasan, M. Shahnaz
Meybohm, Patrick
Ke, Lu
Heyland, Daren K.
Funding for this research was provided by:
Universitätsklinikum Würzburg
Article History
Received: 8 August 2023
Accepted: 26 September 2023
First Online: 18 October 2023
Declarations
:
: The underlying investigator-initiated trial protocol was approved by the Research Ethics Committees of Queen’s University, Canada, and a central institutional review board at Vanderbilt University, TN, USA that granted a waiver of informed consent for sites that acceded to this central institutional review board. Otherwise, where required by local study sites, local ethics approval was obtained, and informed consent was also obtained from designated patient surrogates before randomisation.
: Not applicable.
: The authors do not report a competing interests inside, or related to the present work.